SIOPE-EORTC partnership to maximize quality of paediatric radiotherapy

QUARTET Logo_FinalSIOPE recently kicked off QUARTET (Quality and Excellence in Radiotherapy and Imaging for Children and Adolescents with Cancer across Europe in Clinical Trials) a research project which aims to establish a cross-European quality assurance platform for clinical trials using radiation therapy in the treatment of children and adolescents. To implement this project, SIOPE entered into a partnership with EORTC (European Organisation for Research and Treatment of Cancer) which will be instrumental in improving the quality of radiation therapy and contribute to increase the cure rate of children and adolescents with cancer as well as the quality of life of childhood cancer survivors. QUARTET picture“Quality assurance is essential in radiotherapy to ensure patients get the most benefit from their treatment with the minimum amount of risk,” said Samira Essiaf, Chief Executive Officer at SIOPE. “This project will help establish clear references for the reliable and efficient use of radiation therapy in paediatric oncology, and the EORTC’s rigorous quality control expertise in radiotherapy is key in our decision to enter in this partnership.” “We are honored to be partnering with SIOPE to contribute to this important cross-European project,” said Yan Liu, clinical leader, medical department at EORTC. “Their dedication to improving quality of care and treatment for paediatric oncology patients is fundamentally aligned with the EORTC’s mission to improve treatment for all cancer patients.” More information: